November 2017 - Volume 23 - Issue 11 - Contributor Index

Predictors of Early Readmission in Hospitalized Patients with Inflammatory Bowel Disease

Christian, Kaci E.; Jambaulikar, Guruprasad D.; Hagan, Matilda N.; More

Inflammatory Bowel Diseases. 23(11):1891-1897, November 2017.

Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort

Gonczi, Lorant; Gecse, Krisztina B.; Vegh, Zsuzsanna; More

Inflammatory Bowel Diseases. 23(11):1908-1915, November 2017.

Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort

Gonczi, Lorant; Gecse, Krisztina B.; Vegh, Zsuzsanna; More

Inflammatory Bowel Diseases. 23(11):1908-1915, November 2017.

Enhanced TH17 Responses in Patients with IL10 Receptor Deficiency and Infantile-onset IBD

Shouval, Dror S.; Konnikova, Liza; Griffith, Alexandra E.; More

Inflammatory Bowel Diseases. 23(11):1950-1961, November 2017.

Enhanced TH17 Responses in Patients with IL10 Receptor Deficiency and Infantile-onset IBD

Shouval, Dror S.; Konnikova, Liza; Griffith, Alexandra E.; More

Inflammatory Bowel Diseases. 23(11):1950-1961, November 2017.

Enhanced TH17 Responses in Patients with IL10 Receptor Deficiency and Infantile-onset IBD

Shouval, Dror S.; Konnikova, Liza; Griffith, Alexandra E.; More

Inflammatory Bowel Diseases. 23(11):1950-1961, November 2017.

Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort

Gonczi, Lorant; Gecse, Krisztina B.; Vegh, Zsuzsanna; More

Inflammatory Bowel Diseases. 23(11):1908-1915, November 2017.

Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort

Gonczi, Lorant; Gecse, Krisztina B.; Vegh, Zsuzsanna; More

Inflammatory Bowel Diseases. 23(11):1908-1915, November 2017.

Efficacy of the Autoimmune Protocol Diet for Inflammatory Bowel Disease

Konijeti, Gauree G.; Kim, NaMee; Lewis, James D.; More

Inflammatory Bowel Diseases. 23(11):2054-2060, November 2017.

Enhanced TH17 Responses in Patients with IL10 Receptor Deficiency and Infantile-onset IBD

Shouval, Dror S.; Konnikova, Liza; Griffith, Alexandra E.; More

Inflammatory Bowel Diseases. 23(11):1950-1961, November 2017.

Efficacy of the Autoimmune Protocol Diet for Inflammatory Bowel Disease

Konijeti, Gauree G.; Kim, NaMee; Lewis, James D.; More

Inflammatory Bowel Diseases. 23(11):2054-2060, November 2017.

Epicutaneous Tolerance Induction to a Bystander Antigen Abrogates Colitis and Ileitis in Mice

Dunkin, David; Berin, M. Cecilia; Mondoulet, Lucie; More

Inflammatory Bowel Diseases. 23(11):1972-1982, November 2017.